← back to search

Sumei Wang

Zhejiang Provincial People's Hospital · CN
🔎 Find collaborators in Cancer Research · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Genetics
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer-related molecular mechanisms research, MRI in cancer diagnosis, and MicroRNA in disease regulation.
h-index
39
citations
6,065
works
251
NIH funding
primary concept
email

Recent publications

Fuzheng Kang'ai Formula suppresses NSCLC by inducing a functional crosstalk between autophagy and ferroptosis via EZH2/DOT1L/H3K79me2 signaling.
2026cited by 0position: contributordoi
Mechanisms of drug resistance in hepatocellular carcinoma
Biological Procedures Online 2025cited by 23position: lastdoi
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms
Clinical Epigenetics 2025cited by 14position: lastdoi
Mechanisms of drug resistance in hepatocellular carcinoma.
2025cited by 13position: contributordoi
Treating human cancer by targeting EZH2.
2025cited by 12position: contributordoi
Polyphyllin I induces ferritinophagy dependent ferroptosis through EZH2 and promotes anti-tumor immunity
Biomedicine & Pharmacotherapy 2025cited by 9position: lastdoi
Polyphyllin I induces ferritinophagy dependent ferroptosis through EZH2 and promotes anti-tumor immunity
Biomedicine & Pharmacotherapy 2025cited by 8position: contributordoi
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms.
2025cited by 6position: contributordoi
Targeting Frequent Efferocytosis in Tumor Microenvironment is a New Direction for Cancer Treatment
Small Science 2025cited by 4position: lastdoi
Targeting Frequent Efferocytosis in Tumor Microenvironment is a New Direction for Cancer Treatment.
2025cited by 3position: contributordoi
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses
BMJ Open 2025cited by 2position: lastdoi
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses.
2025cited by 2position: contributordoi
Fuzheng Kang'ai Formula suppresses NSCLC by inducing a functional crosstalk between autophagy and ferroptosis via EZH2/DOT1L/H3K79me2 signaling
Phytomedicine 2025cited by 0position: lastdoi
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Biomedicine & Pharmacotherapy 2024cited by 37position: lastdoi
Treating human cancer by targeting EZH2
Genes & Diseases 2024cited by 17position: lastdoi
FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma
Journal of Ethnopharmacology 2024cited by 13position: contributordoi
Efficacy and Safety of Huachansu as an Adjuvant Therapy for Non-Small Cell Lung Cancer: An Overview of Systematic Reviews and Meta-Analyses
Integrative Cancer Therapies 2024cited by 5position: middledoi
Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers
WORLD SCIENTIFIC eBooks 2024cited by 1position: firstdoi
Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway
Phytomedicine 2023cited by 62position: lastdoi
Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway
Phytomedicine 2023cited by 54position: contributordoi
Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway
Phytomedicine 2023cited by 15position: lastdoi
The application of arsenic trioxide in cancer: An umbrella review of meta-analyses based on randomized controlled trials
Journal of Ethnopharmacology 2023cited by 15position: lastdoi
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer
Carcinogenesis 2023cited by 14position: lastdoi
The complementary and alternative roles of elemene injection in cancer: An umbrella review
Pharmacological Research 2023cited by 14position: lastdoi
FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma
Journal of Ethnopharmacology 2023cited by 13position: lastdoi
The complementary and alternative roles of elemene injection in cancer: An umbrella review.
2023cited by 11position: contributordoi
Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway.
2023cited by 11position: contributordoi
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.
2023cited by 8position: contributordoi
Hovenianin A Alleviates Hepatic Fibrosis by Inhibiting the PI3K/AKT Pathway in TGF‐β1‐Induced HSCs Based on Network Pharmacology and Transcriptomic Analysis
Chemistry & Biodiversity 2023cited by 6position: middledoi
The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review
International Immunopharmacology 2023cited by 6position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Wanyin Wu · Guangzhou University of Chinese Medicine30 papers (2016–2025)Qing Tang · Sichuan University19 papers (2020–2025) · 15 papers (2019–2026)Qichun Zhou · Guangzhou University of Chinese Medicine12 papers (2023–2025)Shunqin Long · Guangzhou University of Chinese Medicine9 papers (2018–2024)Shuqi Chen · Guangzhou University of Chinese Medicine6 papers (2020–2023)Mengfei Xu · Shandong University6 papers (2023–2024)Xinliang Wan · Guangzhou University of Chinese Medicine6 papers (2023–2025)Xiao-Bing Yang · Iowa State University5 papers (2023–2025)François X. Claret · The University of Texas at Austin4 papers (2013–2019)Jixin Chen · Guangzhou University of Chinese Medicine4 papers (2020–2023)Jixin Chen · Guangzhou University of Chinese Medicine4 papers (2022–2025)Ling Han · Fudan University4 papers (2022–2023)Xiaobing Yang · Guangzhou University of Chinese Medicine3 papers (2022–2023)Honghao Sheng · Guangzhou University of Chinese Medicine3 papers (2020–2022)Handan Mo · Guangzhou University of Chinese Medicine3 papers (2024–2025) · 3 papers (2023–2025)Yunbao Pan · Wuhan University3 papers (2013–2016)Xiaoyan Yu · Jilin University3 papers (2025–2025)Shujing Xiao · Guangzhou University of Chinese Medicine2 papers (2018–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Genetics →